US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy
If Approved, AR101 Will Be the First Medicine for This Life-Threatening Condition.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
